Pharma News Briefs

• Last Friday, FDA Law Blog wrote about yet another 180-day exclusivity letter from the FDA, this one requesting comment on the "failure to market" forfeiture provisions of the MMA.
• FDA Law Blog also posted a very nice summary of the FDA Amendments Act, which, among other changes, revises the citizen petition process.
• GSK sued the U.S. Patent & Trademark Office last Tuesday to block implementation of the PTO's new rules restricting patent claims and continuation applications.  Read more here: Patent Docs; Patently-O; Pharmalot; WSJ Health Blog.
• The Wall St. Journal had an interesting article last week on China's generic drug industry.  In case you're not a subscriber to the Journal, you can read the WSJ Health Blog's summary here or Pharmalot's here.
• On October 4, the FDA announced an initiative to streamline the generic drug approval process.  GPhA reacted with skepticism.